Thursday - April 16, 2026

Category Archives: Pharmaceuticals & Biotech

Autism Spectrum Disorder Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Autism Spectrum Disorder Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Autism Spectrum Disorder pipeline landscape. It covers the Autism Spectrum Disorder Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Ulcerative Colitis Clinical Trial Pipeline Expands as 70+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Ulcerative Colitis Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Fabry Disease Market Estimated at USD 1.7 Billion in 2024, Reports DelveInsight

Fabry Disease Market Leading organizations engaged in the Fabry disease domain include Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, GREENOVATION BIOTECH GMBH, Shire, Takeda, Amicus Therapeutics, Protalix, uniQure, Codexis, MP6 Therapeutics, CellGenTech, and several … Continue reading →

Hunter Syndrome Market to Surpass USD 1.2 Billion by 2036 | 15+ Emerging Therapies and 10+ Companies Driving Innovation, analyses DelveInsight

Hunter Syndrome Market The major companies operating in the Hunter Syndrome space include Homology Medicine, Denali Therapeutics, Regenxbio, Takeda, JCR Pharmaceuticals, GC Pharma, Sangamo Therapeutics, ArmaGen, and others. In 2023, the United States represented the largest share of the Hunter … Continue reading →

Platinum-Resistant Ovarian Cancer Market Outlook 2034: Rising Incidence and Robust Pipeline Drive Future Opportunities, analyses DelveInsight

Platinum-Resistant Ovarian Cancer Market Key Platinum-Resistant Ovarian Cancer Companies are Corcept Therapeutics, Advenchen Laboratories, Regeneron Pharmaceuticals, Laekna Therapeutics, and others. The platinum-resistant ovarian cancer market is witnessing growth driven by significant unmet clinical needs, as a large proportion of patients … Continue reading →

Crohn’s Disease Treatment Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Crohn’s Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in Crohn’s Disease pipeline landscape. It covers the Crohn’s Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Mantle Cell Lymphoma Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

DelveInsight’s “Mantle Cell Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Mantle Cell Lymphoma pipeline landscape. It covers the Mantle Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Global Tissue Diagnostics Market Set to Reach $10.86 Billion by 2030 Amid Rising Cancer Burden and Diagnostic Innovation

Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) – Global Forecast to 2030 According to MarketsandMarkets™, the tissue diagnostics market is … Continue reading →

Acute Myeloid Leukemia Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | SystImmune, Jasper Therapeutics, Chimerix, Akeso Biopharma, Syros Pharma, TC Biopharm

The Key Acute Myeloid Leukemia Companies in the market include – SystImmune, Jasper Therapeutics, Chimerix, Akeso Biopharma Co., Ltd., Syros Pharmaceuticals, TC Biopharm, Stemline Therapeutics, Orca Bio, Gilead Sciences, GlycoMimetics, and others.   The Acute Myeloid Leukemia market is expected … Continue reading →